Followers | 1 |
Posts | 74 |
Boards Moderated | 0 |
Alias Born | 12/02/2019 |
![](https://investorshub.advfn.com/uicon/728261.png?cb=1587889295)
Wednesday, March 18, 2020 6:56:54 PM
https://www.roboticsbusinessreview.com/health-medical/rewalk-finalizes-deal-german-health-insurers-exoskeletons/
RWLK is not going away and they are astutely knitting alliances with public and para-public health care insurers in Europe. This is good news. I am now convinced that RWLK is not going to go bankrupt and will survive in the long run. My price target of $7.46 USD/SHR makes more sense now. I will buy more, first thing, tomorrow morning.
Just like in Daniel 2:33 "partly of iron, partly of baked clay".
Partly of parapublic insurance coverage, partly of direct sales and marketing. From there on, we escalate up onto full iron: PROFITABILITY !!!
With my profits, I will fund my conscious artificial intelligence project which will, in time, make the powers that be accountable to a higher power, just like everybody else. Or at least, this is my ambition.
Now, I have 14 hours to decide which stock in my portfolio to sacrifice in order to buy more RWLK.
Banco Santander ? Peabody Energy ? Onconova Therapeutics ? General Motors ? XOM ? TOT ? Certainly not RDS.A nor B. Certainly not ELED.
I have ran out of cash and must sell a deprecated holding to buy more Rewalk Robotics. One that fell less than RWLK and one that has less upwards potential. RWLK is at least a 14 bagger from there on.
I don't think that Banco Santander will go all the way up to $30 USD/SHR, but I do think that RWLK will go all the way up to $7.46 USD/SHR and maybe even higher. OK, Tomorrow I sell my small SAN holding and will use the proceeds to grab more RWLK.
-- Carpe Anima !!!!
Recent RWLK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 08:42:22 PM
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/28/2024 12:30:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 01:00:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:15:21 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/29/2024 12:30:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:16:29 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2024 08:15:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/19/2024 12:46:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/04/2024 01:01:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2024 11:34:09 AM
- VA STAND Act introduced in the United States Senate • GlobeNewswire Inc. • 03/22/2024 12:30:00 PM
- Lifeward Announces Reverse Share Split • GlobeNewswire Inc. • 03/13/2024 03:45:17 PM
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy • GlobeNewswire Inc. • 03/08/2024 01:30:00 PM
- Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may b • GlobeNewswire Inc. • 03/01/2024 01:45:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/27/2024 02:15:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 01:15:25 PM
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/27/2024 01:00:07 PM
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/20/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 09:15:24 PM
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- ReWalk Robotics Expands Direct Sales Coverage to Canada • GlobeNewswire Inc. • 01/12/2024 01:30:00 PM
- ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 • GlobeNewswire Inc. • 01/11/2024 10:00:06 PM
- First ReWalk Personal Exoskeleton Claim Paid by Medicare • GlobeNewswire Inc. • 01/05/2024 01:00:00 PM
- ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities • GlobeNewswire Inc. • 01/04/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 09:04:05 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM